
Burlington Beckons Biotech Growth
Burlington’s latest effort to build a new suburban Boston life science cluster is getting traction among developers and spurring new activity in office parks set to be repositioned with biotech at the forefront.
Burlington’s latest effort to build a new suburban Boston life science cluster is getting traction among developers and spurring new activity in office parks set to be repositioned with biotech at the forefront.
Pursuing lab users continues to be an effective strategy for suburban Boston developers in early 2020, as life science tenants comprised a majority of space commitments in the first quarter.
Life science developer Alexandria Real Estate Equities is giving its first hints about its plans for its newest acquisitions in Watertown and Newton as it explores lab space growth in Boston’s inner suburbs.
A Cambridge biotech startup is moving to Cummings Properties’ TradeCenter 128 complex in Woburn as it prepares to begin clinical trials next spring.